B · Normal
[CRO concept rebounded with shock and Asymptotic hit the daily limit] On November 4th, the CRO concept rebounded with shock and Asymptotic hit the daily limit in the afternoon. Haoyuan Pharmaceutical, Yinuosi, Optima, WuXi AppTec, and Biocytogen were among the top gainers. On the news, according to statistics, the single-quarter revenue of the CXO sector in the third quarter increased by 28.2% year-on-year, and the net profit attributable to the parent company increased by 87.9% year-on-year. The revenue growth rate in the first three quarters reached 25.3%, far exceeding the average level of the pharmaceutical industry.
Comments